- Home
- TSHA vs OCFC Comparison
TSHA vs OCFC Comparison
Compare TSHA & OCFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSHA | OCFC |
|---|---|---|
| Founded | 2019 | 1902 |
| Country | United States | United States |
| Employees | N/A | 1007 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TSHA | OCFC |
|---|---|---|
| Price | $4.44 | $17.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $10.56 | ★ $21.33 |
| AVG Volume (30 Days) | ★ 2.3M | 505.6K |
| Earning Date | 03-19-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | ★ 62.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,333,000.00 | N/A |
| Revenue This Year | N/A | $47.51 |
| Revenue Next Year | N/A | $21.97 |
| P/E Ratio | ★ N/A | $16.71 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | $14.29 |
| 52 Week High | $6.02 | $20.61 |
Technical Indicators
Market Signals| Indicator | TSHA | OCFC |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 31.67 |
| Support Level | $4.39 | $17.28 |
| Resistance Level | $5.16 | $17.63 |
| Average True Range (ATR) | 0.19 | 0.47 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 32.53 | 2.26 |
Price Performance
Historical ComparisonAbout TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.